Literature DB >> 2538434

Identification and characterization of cellular receptors for the growth regulator, oncostatin M.

P S Linsley1, M Bolton-Hanson, D Horn, N Malik, J C Kallestad, V Ochs, J M Zarling, M Shoyab.   

Abstract

Oncostatin M is a polypeptide growth regulator produced by activated T cells and phorbol ester-treated U937 cells. To identify specific cellular receptors for this factor, we have characterized the binding of 125I-labeled oncostatin M to a variety of normal and malignant mammalian cells. Recombinant oncostatin M was labeled with 125I with full retention of growth inhibitory activity on A375 melanoma cells. 125I-Oncostatin M bound to sensitive cells in a time- and temperature-dependent fashion. Binding was specifically inhibited by unlabeled native or recombinant oncostatin M, but not by other polypeptide growth factors tested. Binding to human leukemic and normal blood cells was generally less than to nonhematopoietic cells. With four different cell lines, maximal growth inhibition by oncostatin M was achieved at less than maximal binding site occupancy. Scatchard graphs of direct binding data were curvilinear and indicated that 125I-oncostatin M bound with higher apparent affinity at lower 125I-oncostatin M concentrations. Using a two binding site model, affinity constants of Kd1 = 11 +/- 11 pM and Kd2 = 1000 +/- 380 pM were extrapolated from binding data with A375 cells, and values of Kd1 = 3 +/- 2 pM and Kd2 = 400 +/- 44 pM from A549 cells. The major 125I-oncostatin M binding species in a number of mammalian cell lines was identified by chemical cross-linking as a specific protein(s) of Mr = 150,000-160,000. 125I-Oncostatin M was internalized (t1/2 = 30 min) and degraded subsequent to binding to a responsive cell line.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538434

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.

Authors:  V Modur; M J Feldhaus; A S Weyrich; D L Jicha; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Evaluation and optimization of hepatocyte culture media factors by design of experiments (DoE) methodology.

Authors:  Jia Dong; Carl-Fredrik Mandenius; Marc Lübberstedt; Thomas Urbaniak; Andreas K N Nüssler; Daniel Knobeloch; Jörg C Gerlach; Katrin Zeilinger
Journal:  Cytotechnology       Date:  2008-10-07       Impact factor: 2.058

3.  Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis.

Authors:  Randall E Ryan; Bryan Martin; Liliana Mellor; Reed B Jacob; Ken Tawara; Owen M McDougal; Julia Thom Oxford; Cheryl L Jorcyk
Journal:  Cytokine       Date:  2015-01-23       Impact factor: 3.861

4.  Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6.

Authors:  T M Rose; A G Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

5.  A computer simulation approach to assessing therapeutic intervention points for the prevention of cytokine-induced cartilage breakdown.

Authors:  C J Proctor; C Macdonald; J M Milner; A D Rowan; T E Cawston
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

6.  Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth.

Authors:  M C Amaral; S Miles; G Kumar; A E Nel
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Oncostatin M is a mitogen for rabbit vascular smooth muscle cells.

Authors:  R I Grove; C Eberhardt; S Abid; C Mazzucco; J Liu; P Kiener; G Todaro; M Shoyab
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

8.  Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M.

Authors:  N Malik; J C Kallestad; N L Gunderson; S D Austin; M G Neubauer; V Ochs; H Marquardt; J M Zarling; M Shoyab; C M Wei
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

9.  Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M.

Authors:  P S Linsley; J Kallestad; V Ochs; M Neubauer
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

10.  AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.

Authors:  K Murakami-Mori; T Taga; T Kishimoto; S Nakamura
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.